Wednesday, September 07, 2022 The SC27 study, Living with Cancer in the Time of COVID-19: A Cohort Study of the Impact of the COVID-19 Pandemic on Cancer Patients During Treatment and Survivors has closed to accrual. SC27 was a cohort study of the impact of the COVID-19 pandemic on cancer patients during treatment and survivors. The purpose of the study was to collect information regarding the experience that people living with cancer and cancer survivors have during this COVID-19 pandemic to understand how these experiences could be improved. The study looked at the effects on quality of life, stress, relationships, and quality of health care. For more information please visit the CCTG SC27 Trial Page.
